Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
SpringWorks Therapeutics, Inc.

SpringWorks Therapeutics, Inc. (SWTX) Stock Overview

Explore SpringWorks Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

SWTX●NASDAQ
HealthcareBiotechnology
$46.99
$0.00(0.00%)
U.S. Market is Open · 14:09

SpringWorks Therapeutics, Inc. (SWTX)

Meyka AI Score

Z

Key Financials

Market Cap3.5B
P/E Ratio-13.50
EPS (TTM)$-3.41
ROE-0.47%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$44.35

SWTX Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, SpringWorks Therapeutics, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of SWTX on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $44.35 for the NASDAQ listing.

Key metrics behind SpringWorks Therapeutics, Inc.'s NASDAQ-traded stock include a P/E ratio of -13.50 and a market capitalization of 3.5B. Combined with our AI analysis, these give both institutional and retail investors a clear view of SWTX on the NASDAQ.

Price Performance (NASDAQ: SWTX)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
1.49%
6-Month Change
25.31%
Year-to-Date (YTD) Change
30.24%
1-Year Change
30.85%
3-Year Change
67.46%
5-Year Change
10.23%
All-Time (Max) Change
107.64%

Contact Information

https://www.springworkstx.com
203 883 9490
100 Washington Boulevard, Stamford, CT, 06902

Company Facts

3,680 Employees
IPO DateSep 13, 2019
CountryUS

Frequently Asked Questions